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Abstract 1 
BACKGROUND: Lung cancer is the leading cause of cancer death worldwide. Routine UK lung cancer 2 
screening is not yet available, thus understanding barriers to participation in lung screening could 3 
help maximise effectiveness if introduced. 4 
METHODS: Population-based survey of 1007 adults aged 16 and over in Wales using random quota 5 
sampling. Computer-assisted face-to-face interviews included demographic variables (age, gender, 6 
smoking, social group), four lung cancer belief statements, and three lung screening attitudinal 7 
items. Determinants of lung screening attitudes were examined using multivariable regression 8 
adjusted for age, gender, social group and previous exposure to lung campaign messages. 9 
 10 
RESULTS: Avoidance of lung screening due to fear of what might be found was statistically 11 
significantly associated with negative lung cancer beliefs including fatalism (aOR=8.8, 95% CI=5.6-12 
13.9, p≤Ϭ.ϬϬϭ), low perceived value of symptomatic presentation (aOR=2.4, 95% CI=1.5-3.9, 13 
p≤Ϭ.Ϭ01) and low treatment efficacy (aOR=0.3, CI=0.2-0.7, p≤Ϭ.Ϭϭ). 14 
Low perceived effectiveness of lung screening was significantly associated with fatalism (aOR=6.4, 15 
95% CI=3.5-11.7, p≤Ϭ.ϬϬϭ), low perceived value of symptom presentation (aOR=4.9, 95% CI=2.7-8.9, 16 
p≤Ϭ.ϬϬϭ) and low treatment efficacy (aOR=0.1, 95% CI=0.1-0.3, p≤Ϭ.ϬϬϭ). In contrast, respondents 17 
who thought lung screening could reduce cancer deaths had positive beliefs about lung cancer 18 
(aOR=0.4, 95% CI=0.2-0.7, p≤Ϭ.Ϭ01) and its treatment (aOR=6.1, 95% CI=3.0-12.6, p≤Ϭ.ϬϬϭ).  19 
CONCLUSION: People with negative beliefs about lung cancer may be more likely to avoid lung 20 
screening. Alongside the introduction of effective early detection strategies, interventions are 21 
needed to modify public perceptions of lung cancer, particularly for fatalism. 22 
 23 
 24 
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Title: Attitudes towards lung cancer screening in a population sample 1 
Introduction 2 
Lung cancer is the leading cause of cancer related death worldwide [1]. Five-year cancer survival 3 
rapidly decreases the later lung cancer is diagnosed, due to limited treatments options. In the UK, 4 
when lung cancer is diagnosed at the earliest stage (Stage I), 56% of patients can expect to survive 5 
for one year or more, in comparison to 14% of patients diagnosed at the most advanced stage (Stage 6 
IV) [2]. With 78% of UK non-small cell lung cancer cases diagnosed in the later stages of disease 7 
(Stage III or IV) [2], there is a need to explore strategies to diagnose lung cancer earlier.  8 
Currently, diagnostic testing for suspected lung cancer in the UK requires symptomatic patients to 9 
present to a healthcare professional for referral for further investigation. This approach relies on the 10 
patient and healthcare professional accurately appraising symptoms, which may be problematic for 11 
early diagnosis of lung cancer [3]. Lung cancer symptoms are hard to detect in the early stages, due 12 
to misattribution to smoking habit, co-morbidities or other benign causes [4,5].  13 
Evidence suggests that low-dose computed tomography (CT) screening is effective in detecting early 14 
stage lung cancer [6]. The US National Lung Screening Trial reported a 20% reduction in lung cancer 15 
mortality [6], and is currently the standard of care in the US [7]. Although not routinely available in 16 
the UK, trials are ongoing across Europe to assess the effectiveness of CT lung screening among high 17 
risk groups [8-11]. In the event that lung screening for high risk populations is introduced routinely in 18 
the UK, it is important to understand the barriers to participation and develop interventions to 19 
encourage those who are eligible to engage in lung screening in order to optimise its impact and 20 
maintain cost-effectiveness. 21 
Previous studies of attitudes towards lung cancer screening suggest that smokers from 22 
socioeconomically deprived groups place lower value on the benefits of lung cancer screening, hold 23 
fatalistic beliefs about lung cancer as an untreatable disease, or report stigma as a barrier to 24 
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screening participation [12,13]. In addition, emotional barriers such as fear of lung cancer [14] and 1 
the belief that the lungs are an untreatable organ [12,15] were reported to deter participation in 2 
lung screening trials. However, these studies have been restricted to samples of people over the age 3 
of 40 [12, 13, 15-18]. Therefore, little is known about attitudes to lung screening in a population 4 
sample including younger age groups who may eventually become eligible for programmatic CT lung 5 
screening. Furthermore, there is limited evidence regarding the influences of general beliefs about 6 
lung cancer symptomatic presentation, survival and treatment on attitudes towards lung screening.  7 
A population-based survey was conducted to assess the influence of demographic variables, smoking 8 
status, and beliefs about lung cancer and early symptomatic detection on lung cancer screening 9 
attitudes in a Welsh population sample. It was anticipated that current smokers, respondents from 10 
the lowest socioeconomic group, and those with negative beliefs about lung cancer would have 11 
more negative attitudes towards lung cancer screening.  12 
Materials and Methods  13 
Participants 14 
Ethical approval was obtained to undertake a secondary analysis of population-representative 15 
survey data gathered during February and March 2016, prior to the launch of the Welsh lung cancer 16 
awareness campaign in July 2016 (http://www.cancerresearchuk.org/health-17 
professional/awareness-and-prevention/be-clear-on-cancer/lung-cancer-awareness-campaign-18 
wales). Cancer Research UK commissioned a survey provider (Beaufort Research) to carry out a 19 
nationally representative survey of adults resident in Wales aged 16 years and over, as part of a 20 
commercial Omnibus survey to examine the impact of the campaign on lung symptom awareness.  21 
Pre-campaign survey data were collected from a total of 1007 adults. The number of people who 22 
declined to participate was not recorded, thus the characteristics of survey decliners are unknown. 23 
Design/procedure 24 
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The survey used random quota sampling based on neighbourhoods classified according to census 1 
characteristics. The Omnibus sample is designed to be representative of the adult population 2 
resident in Wales aged 16 and over, with Lower Layer Super Output Area (LSOA) as the unit of 3 
sampling. Sixty-nine interviewing points throughout Wales were selected with probability 4 
proportional to resident population, after stratification by local authority and social group based on 5 
occupation. Socioeconomic group was recorded in four categories using the National Readership Survey 6 
gƌades, ďased oŶ the oĐĐupatioŶ of the household’s Đhief iŶĐoŵe eaƌŶeƌ: AB ;higheƌ aŶd intermediate 7 
managerial, administrative and professional), C1 (supervisory, clerical and junior managerial, 8 
administrative and professional), C2 (skilled manual workers) and DE (semi-skilled and unskilled manual 9 
workers, state pensioners, casual and lowest grade workers, and unemployed with state benefits only). 10 
Categories were combined to cluster participants by social group: ABC1 participants were considered 11 
high socioeconomic status and the C2DE participants were considered low socioeconomic status.  12 
Within each sampling point, quota sample controls of age and social group within gender were set 13 
for the selection of respondents. Quotas were set to reflect the individual demographic profile of 14 
each selected point. A fresh sample of interviewing locations and individuals was selected for each 15 
survey, and no more than one person per household was interviewed. Respondents completed a 16 
computer-assisted interview in the presence of a trained interviewer. Data were weighted by age 17 
group within gender within Local Authority grouping, so that the sample profiles matched those of 18 
people aged 16 years and over in Wales derived from the 2011 Census. 19 
Measures 20 
Survey measures included demographic characteristics (age, gender, social group), smoking history 21 
(smoke up to 20 cigarettes a day, smoke 20 or more cigarettes a day, used to smoke, never smoked), 22 
beliefs about lung cancer, and attitudes towards lung cancer screening. Prior exposure to lung 23 
campaign ŵessages ǁas ŵeasuƌed ďǇ the folloǁiŶg ƋuestioŶs: ͞Haǀe Ǉou seeŶ, heaƌd oƌ ƌead aŶǇ 24 
adverts, publicity or other types of information in the last couple of months which focused on the 25 
5 
 
suďjeĐt of luŶg ĐaŶĐeƌ?͟ RespoŶse optioŶs ǁeƌe ͞Ǉes͟, ͞Ŷo͟ aŶd ͞doŶ’t kŶoǁ / ĐaŶ’t ƌeŵeŵďeƌ͟. A 1 
brief description of lung screening was given: Now I’ŵ goiŶg to read you soŵe stateŵeŶts that are 2 
sometimes made about cancer screening (for example, a mammogram for breast cancer screening, a 3 
poo testing kit for bowel cancer screening). Thinking about lung screening (that is, a chest scan or x-4 
ray), can you tell me how much you agree or disagree with each of the following statements? Items 5 
relating to lung cancer screening attitudes and beliefs about lung cancer were adapted from the ABC 6 
measure [19]. Lung cancer beliefs ǁeƌe assessed ǁith fouƌ iteŵs: ͞I would not want to know if I had 7 
luŶg ĐaŶĐeƌ͟ reflecting cancer fatalism; ͞GoiŶg to ŵǇ GP / doĐtoƌ eaƌlǇ ǁith a sǇŵptoŵ of luŶg 8 
cancer makes no difference to my chances of surviving luŶg ĐaŶĐeƌ͟ reflecting perceived value of 9 
symptom presentation; ͞If luŶg ĐaŶĐeƌ is diagŶosed eaƌlǇ, it is ŵoƌe likelǇ to ďe tƌeataďle͟ reflecting 10 
beliefs about treatment; ͞If I had a Đough, I ǁould ďe ǁoƌƌied aďout ǁastiŶg the GP / doĐtoƌ’s tiŵe͟ 11 
reflecting beliefs about symptomatic presentation. Attitudes towards lung cancer screening were 12 
assessed usiŶg thƌee iteŵs: ͞I would be so worried about what might be found at lung cancer 13 
sĐƌeeŶiŶg that I ǁould pƌefeƌ Ŷot to go͟; ͞I doŶ’t thiŶk theƌe is aŶǇ poiŶt going for lung cancer 14 
screening because it ǁoŶ’t affeĐt the outĐoŵe͟; ͞LuŶg sĐƌeeŶiŶg Đould ƌeduĐe ŵǇ ĐhaŶĐes of dǇiŶg 15 
from cancer͟. RespoŶse optioŶs ǁeƌe stƌoŶglǇ agƌee, agƌee, disagƌee aŶd stƌoŶglǇ disagƌee. ͞DoŶ’t 16 
kŶoǁ͟ ƌespoŶses ǁeƌe ƌeĐoƌded. Responses were recoded for analysis purposes, with strongly agree 17 
aŶd agƌee ĐoŵďiŶed to Đƌeate ͞agƌee͟, aŶd disagree and strongly disagree combined to create 18 
͞disagƌee͟. ͞DoŶ’t kŶoǁ͟ ƌespoŶses ǁeƌe ĐouŶted as ŵissiŶg.  19 
Statistical analysis 20 
Descriptive statistics were used to summarise the demographic characteristics of the sample, and to 21 
assess ŵissiŶg aŶd ͞doŶ’t kŶoǁ͟ ƌespoŶses. Chi square univariable tests were used to examine the 22 
influence of smoking history, age, gender, social group and lung cancer beliefs on endorsement of 23 
attitudes to individual lung cancer screening items. Multivariable regression modelling was carried 24 
out to examine the influence of smoking history and lung cancer beliefs on lung cancer screening 25 
attitudes (individual items), adjusting for age, gender, social group combined, and prior exposure to 26 
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lung cancer messages. The significance level was set at p<0.01 to adjust for multiple testing. To 1 
account for non-representativeness, a weight was applied to the data based on age and gender 2 
within local authority in Wales.  3 
Results 4 
Of a total 1007 participants, 295 (29%) were aged 16-34, 328 (33%) aged 33-54 and 383 (38%) aged 5 
over 55 (see Table 1). There were 518 females (51%) and 489 males (49%), with 406 (41%) from the 6 
social group ABC1 and 596 (60%) from the social group C2DE. Most of the sample had never smoked 7 
(n=433, 43%), 286 (28%) used to smoke, 259 (26%) currently smoked up to 20 cigarettes a day, and 8 
28 (3%) currently smoked more than 20 cigarettes a day (see Table 1). For univarable and 9 
multivariable aŶalǇsis puƌposes, ͞sŵoke up to ϮϬ a daǇ͟ aŶd ͞sŵoke oǀeƌ ϮϬ a daǇ͟ ǁeƌe ĐoŵďiŶed 10 
to Đƌeate a ͞ĐuƌƌeŶtlǇ sŵoke͟ category. 11 
Univariate analysis 12 
Avoidance of lung screening  13 
Fifteen percent (n=144) of the sample endorsed avoidance of lung screening due to fear of what 14 
might be found (Figure 1). Avoidance of lung screening was statistically significantly associated with 15 
fatalism ;p≤ Ϭ.ϬϬϭͿ, low perceived value of symptom pƌeseŶtatioŶ ;p≤ Ϭ.ϬϬϭͿ, haǀiŶg Ŷegatiǀe ǀiews 16 
about treatment ;p≤ Ϭ.ϬϬϭͿ aŶd ǁoƌƌǇ aďout ǁastiŶg the doĐtoƌ’s tiŵe ;p≤ Ϭ.ϬϬϭͿ (see Table 2). 17 
Associations between lung screening attitudes and age, gender, social group, smoking status and 18 
exposure to lung messages were not statistically significant.  19 
Low perceived effectiveness of lung screening 20 
A total of 8% (n=78) endorsed low perceived effectiveness of lung screening (see Figure 1). Low 21 
perceived effectiveness of lung screening was statistically significantly associated with fatalisŵ ;p≤ 22 
0.001), low perceived value of symptom pƌeseŶtatioŶ ;p≤ 0.001), having negative views about 23 
tƌeatŵeŶt ;p≤ Ϭ.ϬϬϭͿ aŶd ǁoƌƌǇ aďout ǁastiŶg the doĐtoƌ’s tiŵe ;p≤ Ϭ.ϬϬϭͿ (see Table 3). Effects of 24 
7 
 
age, gender, smoking status, social group and exposure to lung messages were not statistically 1 
significant.  2 
Lung screening to reduce mortality  3 
Ninety percent (n=859) of the sample agreed that lung screening could reduce lung cancer death 4 
(Figure 1). Agreeing that lung screening could reduce chances of dying from cancer was associated 5 
with positive lung cancer beliefs reflecting lack of fatalism ;p≤ Ϭ.ϬϬϭͿ, aŶd haǀiŶg positiǀe ǀieǁs 6 
about treatment ;p≤ Ϭ.ϬϬϭͿ (see Table 4). There were no statistically significant effects of any 7 
demographic variables.  8 
Logistic regression 9 
Regression analysis was completed using the weighted data, adjusting for age, gender, social group 10 
and previous exposure to lung messages. 11 
Avoidance of lung screening  12 
Negative lung cancer beliefs including fatalism (aOR = 8.8 CI=5.6-13.9, p ≤ Ϭ.ϬϬϭͿ, loǁ perceived 13 
value of symptom presentation (aOR = 2.4, CI=1.5-3.9, p≤ Ϭ.001) and having negative views about 14 
treatment (aOR = 0.3, CI=0.2-0.7, p≤ Ϭ.ϬϭͿ shoǁed a statistiĐallǇ sigŶifiĐaŶt assoĐiatioŶ ǁith Ŷot 15 
wanting to have lung screening due to being worried about what might be found (see Table 5). 16 
“ŵokiŶg status aŶd ďeiŶg ǁoƌƌied aďout ǁastiŶg the doĐtoƌ’s tiŵe ǁeƌe Ŷot statistically significantly 17 
associated with lung cancer screening avoidance due to worry about the outcome.  18 
Low perceived effectiveness of lung screening 19 
Negative lung cancer beliefs including fatalism (aOR = 6.4 CI=3.5-11.7, p ≤ Ϭ.ϬϬϭͿ, loǁ peƌĐeiǀed 20 
value of symptom presentation (aOR = 4.9, CI=2.7-8.9, p≤ Ϭ.ϬϬϭͿ aŶd having negative views about 21 
treatment (aOR = 0.1, CI=0.1-0.3, p≤ Ϭ.ϬϬϭͿ showed a statistically significant association with low 22 
perceived effectiveness of lung screening (see Table 5). Smoking status and being worried about 23 
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ǁastiŶg the doĐtoƌ’s tiŵe ǁeƌe Ŷot statistically significantly associated with attitudes towards the 1 
efficacy of screening.  2 
Lung screening to reduce mortality  3 
Positive lung cancer beliefs reflecting lack of fatalism (aOR = 0.4 CI=0.2-0.7, p ≤ Ϭ.Ϭ01) and positive 4 
views about treatment (aOR = 6.1, 95% CI=3.0-12.6, p≤ Ϭ.ϬϬϭͿ shoǁed a statistiĐallǇ sigŶifiĐaŶt 5 
association with agreeing that lung screening could reduce chances of dying from cancer (see Table 6 
5). “ŵokiŶg status, ďeliefs aďout eaƌlǇ pƌeseŶtatioŶ, aŶd ďeiŶg ǁoƌƌied aďout ǁastiŶg the doĐtoƌ’s 7 
time were not significantly associated with perceptions that lung screening could reduce lung cancer 8 
mortality.  9 
Discussion  10 
To our knowledge, the present study was the first to test associations with lung cancer screening 11 
attitudes using quantitative survey methods in a population sample of adults over the age of 16. 12 
Attitudes towards lung cancer screening were generally positive, with over 90% of survey 13 
respondents believing that there was benefit to lung cancer screening in terms of lung cancer 14 
outcomes and survival, and may encourage participation in lung cancer screening. However, those 15 
who endorse negative beliefs about lung cancer may be more likely to avoid lung screening. 16 
Respondents who endorsed negative beliefs about lung cancer - reflecting fatalism, low perceived 17 
effectiveness of symptom presentation and negative views about treatment - were more likely to 18 
hold negative attitudes towards lung cancer screening. Smoking status was not significantly 19 
associated with attitudes towards lung cancer screening in the current study.  20 
Our findings mirror those of previous studies that have examined participation in a colorectal cancer 21 
screening context, where over 90% of respondents in an Australian population based study held 22 
positive beliefs about colorectal cancer screening [20]. In addition, positive beliefs about the benefits 23 
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of colorectal cancer screening have been associated with increased anticipated uptake of screening 1 
[21] and participation in screening [20,22].  2 
The current study suggests that negative beliefs about lung cancer were associated with lung 3 
screening avoidance, particularly fatalism, suggesting that those who decline screening would prefer 4 
not to know if they have lung cancer, potentially due to fear of treatment and lung cancer death. 5 
Our findings are in line with previous research highlighting fear of lung cancer [12-14] and fatalism, 6 
including beliefs about the treatment for lung cancer [12, 15] as barriers to participation in lung 7 
cancer screening. It is likely that avoidance of lung screening and negative beliefs may reflect lung 8 
cancer stigma [23], possibly due to the relationship between lung cancer and smoking, and poor lung 9 
cancer outcomes. 10 
The absence in our study of an observed association between smoking status and lung cancer 11 
screening attitudes contradicts the findings of previous studies, which have highlighted more 12 
negative screening attitudes among current smokers [12, 24]. In addition, former smokers have been 13 
shown to be over-represented in lung cancer screening trials [25,26]. Our contradictory findings are 14 
likely to reflect the limited representation of heavy smokers in our sample and consequent low 15 
statistical power. Poor representation from current smokers should be noted as a limitation of this 16 
study. Future work focusing on attitudes in heavy, moderate and light smokers would help to further 17 
understanding of the influence of nicotine dependence on screening attitudes. It should also be 18 
noted that the associations between lung cancer beliefs and lung screening attitudes may partly 19 
reflect shared method variance, where associations between variables can be inflated when 20 
measures are taken at the same point in time. Prospective longitudinal research should therefore be 21 
undertaken to examine the predictors of lung screening uptake and outcomes. Finally, we used an 22 
adapted version of the ABC measure in the absence of a validated measure of lung screening at the 23 
time of survey development. Future studies could consider using a recently developed and 24 
psychometrically validated measure of lung screening health beliefs [27].  25 
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Our findings suggest that negative beliefs about lung cancer may deter participation in lung cancer 1 
screening. Therefore addressing population beliefs about lung cancer is an important step before the 2 
implementation of a lung screening programme. Public awareness campaigns should focus on the 3 
benefits of lung cancer screening, where early detection increases survival through access to more 4 
effective treatments, to modify fatalistic beliefs about lung cancer survival and treatment. 5 
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